Home » news »

Candida antigen safe, effective for treating common warts

 

(HealthDay)—Candida antigen is a promising, effective, and protected immunotherapeutic diagnosis for common warts, according to a investigate published online Aug. 8 in a International Journal of Dermatology.

Ahmad Nofal, M.D., from Zagazig University in Egypt, and colleagues evaluated a efficiency and reserve of Candida antigen for a diagnosis of common warts and a stress of interferon gamma (IFN-?) in a prophecy of successful therapy. Blood samples were collected from 54 patients with mixed common warts before therapy, cultured, and treated with Candida antigen for analysis of IFN-?. Direct injections of Candida antigen were done into a largest wart during two-week intervals until finish clearway or for a limit of 5 treatments.

The researchers found that finish clearway of a lesions was seen in 61.1 percent of a complicated patients. Among cases that responded, IFN-? was statistically higher, compared to that seen in non-responders. No poignant inauspicious effects or regularity of warts was observed.

Candida antigen is a promising, effective, and protected immunotherapeutic modality for common warts, and IFN-? might offer as a good predictor of a healing response,” a authors write.


Explore further:
Immunotherapy improved than cryotherapy for wart lesions

More information:
Abstract
Full Text (subscription or remuneration might be required)

feedback
feedback to editors

 

Related Posts

  • No Related Posts